Status:
UNKNOWN
Validation of an Intermittent Shuttle Walking Protocol in Patients With COPD
Lead Sponsor:
Northumbria University
Collaborating Sponsors:
Royal Victoria Infirmary
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
40-75 years
Phase:
NA
Brief Summary
In the UK, field-based walking is prescribed in the pulmonary rehabilitation (PR) setting as a convenient, less resource-intensive, and highly responsive exercise modality in COPD patients. However, e...
Detailed Description
Although previous research in the area of pulmonary rehabilitation in COPD has documented that high intensity exercise induces greater benefits than moderate intensity exercise, patients with advanced...
Eligibility Criteria
Inclusion
- Male or female aged 40 years or older.
- Current or previous smoking history: 10 or more pack years.
Exclusion
- Orthopaedic, neurological or other concomitant diseases that significantly impair normal biomechanical movement patterns, as judged by the investigator.
- Moderate or severe COPD exacerbation within 6 weeks.
- Unstable cardiac arrhythmia.
- Unstable ischaemic heart disease, including myocardial infarction within 6 weeks.
- Moderate or severe aortic stenosis or hypertrophic obstructive cardiomyopathy.
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04326855
Start Date
October 1 2020
End Date
September 30 2022
Last Update
March 30 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.